Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174;…
News
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
Mainz, Germany, December 02, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
Innate Pharma 2021 financial calendar
Marseille, Dec. 02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN:…
Innate Pharma 2021 Financial Calendar
MARSEILLE, France, Dec. 02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers
Basel, 2 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the…
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome…
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or…
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein…
Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
OV101 program in Angelman syndrome to pause pending full analysis of NEPTUNE trial and discussions…